Putting immunoinformatics to the test
暂无分享,去创建一个
[1] Stuart M. Brown,et al. Genomics‐based identification of self‐ligands with T cell receptor‐specific biological activity , 2002, Immunological reviews.
[2] R. Valenta,et al. Can we genetically engineer safer and more effective immunotherapy reagents? , 2003, Current opinion in allergy and clinical immunology.
[3] J. Markmann,et al. Homeostatic proliferation is a barrier to transplantation tolerance , 2004, Nature Medicine.
[4] G. Nepom,et al. MHC Class II tetramers and the pursuit of antigen-specific T cells: define, deviate, delete. , 2004, Clinical immunology.
[5] B. Rapoport,et al. Schistosoma mansoni and α-Galactosylceramide: Prophylactic Effect of Th1 Immune Suppression in a Mouse Model of Graves’ Hyperthyroidism , 2004, The Journal of Immunology.
[6] W. Martin,et al. De-immunization of therapeutic proteins by T-cell epitope modification. , 2005, Developments in biologicals.
[7] Bjoern Peters,et al. HLA-A*0201, HLA-A*1101, and HLA-B*0702 Transgenic Mice Recognize Numerous Poxvirus Determinants from a Wide Variety of Viral Gene Products1 , 2005, The Journal of Immunology.
[8] Francisco A. Chaves,et al. The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance. , 2005, Immunity.
[9] L. K. Ely,et al. Antagonism of Antiviral and Allogeneic Activity of a Human Public CTL Clonotype by a Single Altered Peptide Ligand: Implications for Allograft Rejection 1 , 2005, The Journal of Immunology.
[10] R. Welsh,et al. Private specificities of CD8 T cell responses control patterns of heterologous immunity , 2005, The Journal of experimental medicine.
[11] Magdalini Moutaftsi,et al. A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus , 2006, Nature Biotechnology.
[12] A. D. De Groot,et al. Thyrotropin receptor epitopes and their relation to histocompatibility leukocyte antigen-DR molecules in Graves' disease. , 2006, The Journal of clinical endocrinology and metabolism.